OLGA GORLOVA to Mutation, Missense
This is a "connection" page, showing publications OLGA GORLOVA has written about Mutation, Missense.
Connection Strength
0.524
-
Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes. Oncotarget. 2022; 13:756-767.
Score: 0.147
-
Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples. BMC Bioinformatics. 2018 Nov 19; 19(1):430.
Score: 0.115
-
Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53. Hum Mutat. 2005 Nov; 26(5):446-54.
Score: 0.047
-
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutat Res. 2004 Oct 04; 554(1-2):175-83.
Score: 0.043
-
Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden. Sci Rep. 2024 06 03; 14(1):12732.
Score: 0.042
-
Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003 Nov; 73(5):1157-61.
Score: 0.040
-
Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun. 2020 05 11; 11(1):2220.
Score: 0.032
-
Untouchable genes in the human genome: Identifying ideal targets for cancer treatment. Cancer Genet. 2019 02; 231-232:67-79.
Score: 0.029
-
Relative effects of mutability and selection on single nucleotide polymorphisms in transcribed regions of the human genome. BMC Genomics. 2008 Jun 17; 9:292.
Score: 0.014
-
Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008 Jan; 82(1):100-12.
Score: 0.014